Treatment of Disseminated Nocardiosis with CNS Dissemination and Cerebral Abscess
Clinical scenario
This protocol addresses disseminated nocardiosis in patients with central nervous system involvement — specifically those presenting with cerebral abscess. CNS dissemination defines a severe disease form requiring a distinct management approach from localised infection.
Key presentation
The most common site of dissemination in nocardiosis is the central nervous system, typically manifesting as cerebral abscesses. This pattern demands close attention to CNS penetration in treatment planning and to radiographic monitoring of lesion response.
Treatment approach — partial overview
Management is built around empiric combination therapy using agents selected for CNS penetration. In patients with larger cerebral abscesses, neurosurgical intervention may form part of the approach. Treatment duration for CNS disease is typically prolonged — commonly at least 12 months.
Agent selection, sequencing, dosing strategy, and the full clinical algorithm are available in the complete structured protocol.
Goal: Radiographic resolution of cerebral abscess on follow-up brain imaging
References
DOI: 10.1093/cid/ciae643
- The most common site of dissemination is the central nervous system (CNS), typically manifesting as cerebral abscesses.
- This is particularly crucial in severe forms of nocardiosis (eg, disseminated or progressive pulmonary infection), where 2 or 3 different agents are typically initiated empirically.
- In CNS nocardiosis specifically, about half of patients undergo abscess debridement or stereotactic needle aspiration.
- Patients with localized pulmonary nocardiosis are traditionally treated for up to 6 months, while those with disseminated disease (particularly involving the CNS) are commonly treated for at least 12 months.
- Patients with CNS involvement are commonly treated until radiographic resolution, though CNS lesions may not fully resolve and evidence supporting this practice is lacking.
View source ↗